Patents Examined by Donna A. Jagoe
  • Patent number: 6337075
    Abstract: The invention encompasses a method for treating hyperinsulinemic type 2 diabetes by local administration of a neurotoxin, such as a botulinum toxin, into the pancreas, thereby reducing insulin secretion from a B cell, and a method for treating hypoinsulinemic type 2 diabetes by local administration of a neurotoxin, such as a botulinum toxin, into a sympathetic ganglion, thereby reducing an inhibitory effect upon insulin secretion.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: January 8, 2002
    Assignee: Allergan Sales, Inc.
    Inventor: Stephen Donovan
  • Patent number: 6159965
    Abstract: A non-sedating anti-emetic composition in oral unit dosage form comprising from 1 to 5 mg of methotrimeprazine per unit dosage, or in unit dosage form for parenteral administration comprising from 1 to 5 mg of methotrimeprazine in each unit dosage.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: December 12, 2000
    Assignee: Link Pharmaceuticals Limited
    Inventors: Philip Malcolm Hallwood, Grahame David Barkby
  • Patent number: 6083927
    Abstract: A hepatic disturbance improver which reduces fat in hepatocytes which includes an oligosaccharide of formula (1), (2) or (3), obtainable by hydrolyzing porphyran contained in seaweed of the genus Porphyra. The hepatic disturbance improver is advantageous, in that it reduces fat in hepatocytes without causing side effects.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: July 4, 2000
    Assignees: Shirako Co., Ltd., Hokkaido Sugar Co., Ltd.
    Inventors: Yukihiro Osumi, Kazuhito Moriya, Tadashi Sasazuka